Roles of P2X7 receptor in glial and neuroblastoma cells: The therapeutic potential of P2X7 receptor antagonists

Molecular Neurobiology

Volumn 41, Issue 2-3, 2010, Pages 351-355

  Sun, Synthia H ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Astrocytes; N2a neuroblastoma cells; Oxidized ATP. P2X7 receptor; P2X7 receptor antagonists

Indexed keywords

2',3' O (4 BENZOYLBENZOYL)ADENOSINE TRIPHOSPHATE; A 438079; ADENOSINE TRIPHOSPHATE DERIVATIVE; BRILLIANT BLUE G; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; PERIODATE OXIDIZED 2',3' DIALDEHYDE ADENOSINE TRIPHOSPHATE; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; RETINOIC ACID; UNCLASSIFIED DRUG; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ISOPROTEIN; PURINERGIC P2 RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ASTROCYTE; B CELL LEUKEMIA; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER CELL; CELL CYCLE PROGRESSION; CELL DEATH; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL VIABILITY; CHANNEL GATING; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; CYTOSOL; DRUG POTENCY; DRUG SAFETY; DRUG SELECTIVITY; ELECTROPHYSIOLOGY; EXCITOTOXICITY; EXTRACELLULAR SPACE; GLIA CELL; HUMAN; INFLAMMATION; MICROGLIA; MONOCYTE; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NEUROPATHIC PAIN; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; PROSTATE CANCER; SEQUENCE HOMOLOGY; ANIMAL; CELL DIFFERENTIATION; CELL SURVIVAL; DRUG ANTAGONISM; GLIA; METABOLISM; NEUROBLASTOMA; PHYSIOLOGY; REVIEW;

ANIMALS; CALCIUM; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; HUMANS; NEUROBLASTOMA; NEUROGLIA; NEUROTRANSMITTER AGENTS; PROTEIN ISOFORMS; RECEPTORS, PURINERGIC P2;

EID: 77955087130     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12035-010-8120-x     Document Type: Conference Paper

References (60)

1. Burnstock G (1997) The past, present and future of purine nucleotides as signaling molecules. Neuropharmacology 36:1127-1139
2. Newman EA (2003) New roles for astrocytes: regulation of synaptic transmission. Trend Neurosci 26:536-542
3. El-Moatassim C, Dubyak GR (1993) Dissociation of the por-eforming and phospholipase D activities stimulated via P2Z purinergic receptors in BAC1.2F5 macrophages. J Biol Chem 268:15571-15578
4. Steinberg TH, Newmann AS, Swanson JA, Silverstein SC (1987) Extracellular ATP42 promotes cation fluxes in the J774 in the mouse macrophage cell line. J Biol Chem 262:8884-8888
5. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067
6. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G (1996) The cytolytic P2z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735-738
7. Ferrari D, Villalba M, Chiozzi P, Falzoni S, Ricciardi-Castagnoli P, DiVirgilio F (1996) Mouse microglia cells express a plasma membrane pore gated by extracellular ATP. J Immunol 156:1531-1539
8. Ballerini P, Rathbone MP, Di Lorio P, Renzetti A, Giuliani P, D'Alimonte I, Trubiani O, Caciagli F, Ciccarelli R (1996) Rat astroglial P2Z (P2X7) receptors regulate intracellular calcium and purine release. NeuroReport 7:2533-2537
9. Nobile M, Monaldi I, Alloisio S, Cugnoli C, Ferroni S (2003) ATP-induced, sustained calcium signalling in cultured rat cortical astrocytes: evidence for a non-capacitative, P2X7-like-mediated calcium entry. FEBS Lett 538:71-76
10. 7 receptors. J Neurochem 73:334-343
11. 7 receptors are targeted to presynaptic terminals in the central and peripheral nervous system. J Neurosci 21:7143-7152
12. Williams N, Coleman PS (1982) Exploring the adenine nucleotide binding sites on mitochondrial F1-ATPase with a new photo-affinity probe, 3'-O-(4-benzoyl)benzoyl adenosine 5'-tri-phosphate. J Biol Chem 257:2834-2841
13. Gonzalez FA, Ahmed AH, Lustig KD, And EL, Weisman GA (1989) Permeabilization of transformed mouse fibroblasts by 3'-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate and the desensi-tization of the process. J Cell Physiol 139:109-115
14. 7 receptor. Curr Top Med Chem 4:1707-1717
15. Harden TK, Boyer JL, Nicholas RA (1995) P2-purinergic receptors: subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol 35:541-579
16. Boarder MR, Hourani SMO (1998) The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol Sci 19:99-107
17. Murgial M, Hanaug S, Pizzol P, Rippag M, Di Virgio F (1993) Oxidized ATP. J Biol Chem 266:8199-8203
18. 7 receptors decreases glutamate uptake and glutamine synthetase activity in RBA-2 astrocytes via distinct mechanisms. J Neurochem 105:151-164
19. 7 receptor impairs ATP-induced IL-1 release from human monocytes. J Immunol 172:3399-3405
20. 7 receptor-mediated release of excitatory amino acids from astrocytes. J Neurosci 23:1320-1328
21. Pelegrin P, Surprenant A (2006) Pannexin-1 mediates large pore formation and interleukin-1b release by the ATP-gated P2X7 receptor. EMBO J 25:5071-5082
22. Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H (2003) Pannexins, a family of gap junction proteins expressed in brain. PNAS 100:13644-13649
23. Stout CE, Costantin JL, Naus CCG, Charles AC (2002) Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 277:10482-10488
24. Ye Z-C, Wyeth MS, Baltan-Tekkok S, Ransom BR (2003) Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J Neurosci 23:3588-3596
25. 2+ signaling. J Neurosci 26:1378-1385
26. Wilkin GP, Marriott DR, Cholewinski AJ (1990) Astrocyte heterogeneity. Trends Neurosci 13:43-46
27. Wang C-M, Chang Y-Y, Kuo J-S, Sun SH (2002) Activation of P2X7 receptors induced [3H]GABA release from RBA-2 type-2 astrocyte cell line through a Cl-/HCO3-dependent mechanism. Glia 37:8-18
28. Anderson CM, Bergher JP, Swanson RA (2004) ATP-induced ATP release from astrocytes. J Neurochem 88:246-256
29. Virginio C, Church D, North RA, Surprenant A (1997) Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neurophannacology 36:1285-1294
30. Le Feuvre R, Brough D, Rothwell N (2002) Extracellular ATP and P2X7 receptors in neurodegeneration. Eur J Pharmacol 447:261-269
31. Ferrari D, Chiozzi P, Falzoni S, Dal SM, Melchiorri L, Baricordi OR, Di Virgilio F (1997) Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159:1451-1458
32. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, Griffiths RJ, Gabel CA (2001) Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276:125-132
33. Ferrari D, Chiozzi P, Falzoni S, Dal SM, Collo G, Buell G, Di Virgilio F (1997) ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36:1295-1301
34. Chakfe Y, Seguin R, Antel JP, Morissette C, Malo D, Henderson D, Séguéla P (2002) ADP and AMP induce interleukin-1β release from microglial cells through activation of ATP-primed P2X7 receptor channel. J Neurosci 22:3061-3069
35. 2+ in regulation of IL-1β secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am J Physiol Cell Physiol 285:C286-C299
36. Sanz JM, Di Virgilio F (2000) Kinetics and mechanism of microglial cells ATP-dependent IL-1ß release from microglial cells. J Immunol 164:4893-4898
37. 2+ on P2z purinoceptor-associated pores in dibutyryl cyclic AMP-differentiated NG108-15 cells. J Neurochem 67:1694-1701
38. 2+ channel function. J Neuro-chem 83:285-298
39. 7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res 66:907-914
40. Resta V, Novelli E, Di Virgilio F, Galli-Resta L (2005) Neuronal death induced by endogenous extracellular ATP in retinal cholinergic neuron density control. Development 132:2873-2882
41. 7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99:706-708
42. 7 ATP receptor. J Biol Chem 274:33206-33208
43. Slater M, Danieletto S, Gidley-Baird A, Teh LC, Barden JA (2004) Early prostate cancer detected using expression of nonfunctional cytolytic P2X7 receptors. Histopathology 44:206-215
44. 7 receptor promotes axonal growth and branching in cultured hippocampal neurons. J Cell Sci 121:3717-3728
45. 7 receptors are associated with retinoic acid-induced neuronal differentiation of Neuro-2a neuroblastoma cells. Cell Signal 21:881-891
46. 7 receptor channel opening in the absence of exogenous ligands. Glia 57:622-633
47. 2+/calmodulin-dependent kinase II signalling cascade mediates P2X7 receptor-dependent inhibition of neuritogenesis in neuroblastoma cells. FEBS J 276:5307-5325
48. Alcaraz L, Baxter A, Bent J, Bowers K, Braddock M, Cladingboel D, Donald D, Fagura M, Furber M, Laurent C, Lawson M, Mortimore M, McCormick M, Roberts N, Robertson M (2003) Novel P2X7 receptor antagonists. Bioorg Med Chem Lett 13:4043-4046
49. Stokes L, Jiang L-H, Alcaraz L, Bent A, Bowers K, Fagura M, Furber M, Mortimore M, Lawson M, Theaker J, Laurent C, Braddock M, Surprenant A (2006) Characterization of a selective and potent antagonist of human P2X7 receptors, AZ11645373. Br J Pharmacol 149:880-887
50. Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, Hernandez G, Zhong C, Gauvin DM, Chandran P, Harris R, Medrano AP, Carroll W, Marsh K, Sullivan JP, Faltynek CR, Jarvis MF (2006) A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl] amino}-2, 2-dimethylpropyl)-2- (3, 4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Therapeu 319:1376-1385
51. 7 receptor function and indicates a role in chronic pain states. Br J Pharmacol 151:571-579
52. Florjancic AS, Peddi S, Perez-Medrano A, Li B, Namovic MT, Grayson G, Donnelly-Roberts DL, Jarvis MF, Carroll WA (2008) Synthesis and in vitro activity of 1-(2, 3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1, 2, 4-triazol-5-amine and 4-(2, 3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1, 2, 4-triazol-3-amine P2X7 antagonists. Bioorganic Med Chem Letters 18:2089-2092
53. 7 antagonist in animal models of pain and inflammation. J Pharmacol Exp Ther 327:620-633
54. Matute C, Torre I, Pérez-Cerdá F, Pérez- Samartín A, Alberdi E, Etxebarria E, Arranz AM, Ravid R, Rodríguez-Antigüedad A, Sánchez-Gómez MV, Domercq M (2007) P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci 27:9525-9533
55. Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, Li P, Xu Q, Liu SQ, Goldman SA, Nedergaard M (2004) P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10:821-827
56. Peng W, Cotrina ML, Han X, Yu H, Bekar L, Blum L, Takano T, Tian G-F, Goldman SA, Nedergaard M (2009) Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. PNAS 106:12489-12493
57. Jiang L-H, Mackenzie AB, North RA, Surprenant A (2000) Brilliant blue G selectively blocks ATP-gated rat P2X7 receptors. Mol Pharmacol 58:82-88
58. Beigi RD, Kertesy SB, Aquilina G, Dubyak GR (2003) Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms. Br J Pharmacol 140:507-519
59. 7 receptor. Eur J Pharmacol 550:1-7
60. Ferrari D, Pizzirani C, Adinolfi E, Lemoli L, Curti A, Idzko M, Panther E, Di Virgilio F (2006) The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176:3877-3883